THW (Tekla World Healthcare Fund) Moat Score: 2/10 (As of Jul. 08, 2026)


THW Tekla World Healthcare Fund THW
57 GF Score
Price $13.49
GF Value $19.36
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Tekla World Healthcare Fund Moat Score?

Tekla World Healthcare Fund THW -1.32% 57 Moat Score is 2 as of Jul. 08, 2026. GuruFocus rates THW with a GF Score™ of 57/100 and a GF Value™ of $19.36 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 1,698 Asset Management companies, Tekla World Healthcare Fund ranks better than 80.09% on this metric.

Tekla World Healthcare Fund has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Tekla World Healthcare Fund has No Moat: THW, as a healthcare fund, lacks unique competitive advantages. It does not have proprietary technology, brand strength, or significant market share, facing competition from numerous similar funds.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Tekla World Healthcare Fund might have No Moat - Very weak/transient advantages.

Tekla World Healthcare Fund  (NYSE:THW) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Tekla World Healthcare Fund Moat Score Related Terms

THW vs MSIF, IQI, TWN: Moat Score Comparison

For the Asset Management subindustry, Tekla World Healthcare Fund's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tekla World Healthcare Fund Moat Score vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Tekla World Healthcare Fund's Moat Score distribution charts can be found below:

* The bar in red indicates where Tekla World Healthcare Fund's Moat Score falls into.


THW
57GF Score
Tekla World Healthcare Fund THW
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Tekla World Healthcare Fund (THW) has a Moat Score of 2 as of Jul. 08, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Tekla World Healthcare Fund ranks #338 out of 1698 companies in the Asset Management industry, placing it in the top 19.9%.
Is Tekla World Healthcare Fund's Moat Score too high?
Tekla World Healthcare Fund's current Moat Score is 2. Based on the distribution chart, Tekla World Healthcare Fund ranks #338 out of 1698 companies in the Asset Management industry, which is in the top quartile — a strong position relative to peers. Overall, Tekla World Healthcare Fund has a GF Score™ of 57/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tekla World Healthcare Fund's Moat Score compare to MSIF and IQI?
According to the Asset Management industry distribution chart, Tekla World Healthcare Fund ranks #338 out of 1698 companies for Moat Score. This places Tekla World Healthcare Fund in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for an Asset Management company?
A good Moat Score depends on the Asset Management industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Tekla World Healthcare Fund's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tekla World Healthcare Fund stock overvalued right now?
Based on GuruFocus' analysis, Tekla World Healthcare Fund (THW) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.36, compared to a current price of $13.49 — trading 30.3% below its estimated fair value. The current Moat Score is 2. Tekla World Healthcare Fund's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Tekla World Healthcare Fund (THW), the current Moat Score is 2 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tekla World Healthcare Fund (THW) Overvalued in 2026?

Based on GuruFocus' analysis, Tekla World Healthcare Fund stock appears to be undervalued. The current stock price of $13.49 is trading 30.3% below its estimated GF Value™ of $19.36. GuruFocus considers Tekla World Healthcare Fund to be Significantly Undervalued.

Key valuation signals for THW:

  • Moat Score: 2
  • GF Value™: $19.36 vs. price of $13.49 (30.3% below fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the THW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tekla World Healthcare Fund Business Description

Address 1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.
57GF Score

Get the complete analysis for THW

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.49
Price
$19.36
GF Value